GlaxoSmithKline
GSK
$33.79
Share price
-1.31%
Change (1 day)
-23.03%
Change (1 year)
Categories
Earnings for GlaxoSmithKline (GSK)
Earnings in 2023 (TTM): $6.55 B
According to GlaxoSmithKline's latest financial reports the company's current earnings (TTM) are $6.55 B. In 2022 the company made an earning of $7.60 B an increase over its 2021 earnings that were of $7.42 B.The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Earnings history for GlaxoSmithKline from 2001 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
| 2023 (TTM) | $6.55 B | -13.83% |
| 2022 | $7.60 B | 2.43% |
| 2021 | $7.42 B | -15.57% |
| 2020 | $8.79 B | 10.81% |
| 2019 | $7.93 B | 25.28% |
| 2018 | $6.33 B | 37.91% |
| 2017 | $4.59 B | 80.02% |
| 2016 | $2.55 B | -83.68% |
| 2015 | $15.63 B | 219.06% |
| 2014 | $4.89 B | -53.64% |
| 2013 | $10.56 B | -1.3% |
| 2012 | $10.70 B | -12.13% |
| 2011 | $12.18 B | 149.01% |
| 2010 | $4.89 B | -60.81% |
| 2009 | $12.48 B | 2.43% |
| 2008 | $12.19 B | -19.37% |
| 2007 | $15.12 B | 4.65% |
| 2006 | $14.44 B | 19.85% |
| 2005 | $12.05 B | 5.67% |
| 2004 | $11.40 B | 12.66% |
| 2003 | $10.12 B | 48.93% |
| 2002 | $6.79 B | -9.52% |
| 2001 | $7.51 B |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 Novartis NVS | $8.44 B | 28.88% | 🇨🇭 Switzerland |
 Pfizer PFE | $33.18 B | 406.60% | 🇺🇸 USA |
 Sanofi SNY | $9.32 B | 42.39% | 🇫🇷 France |
 Merck MRK | $16.46 B | 151.37% | 🇺🇸 USA |
 AstraZeneca AZN | $5.58 B | -14.75% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | -$1.39 B | -121.13% | 🇮🇱 Israel |
 Dynavax Technologies
DVAX | $0.24 B | -96.27% | 🇺🇸 USA |